Cargando…
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications
BACKGROUND: Previous studies reported higher incidences of venous thromboembolism and cardiovascular disease in schizophrenia patients and higher indicators of thrombosis, thrombocyte activation, and platelet dysfunction. OBJECTIVES: To check if first-episode schizophrenia (FES) patients have a hype...
Autores principales: | Zheng, Caiji, Liu, Haiyan, Tu, Weifeng, Lin, Lingyun, Xu, Haiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540600/ https://www.ncbi.nlm.nih.gov/pubmed/37781686 http://dx.doi.org/10.1177/20451253231200257 |
Ejemplares similares
-
Treatment of hypercoagulation state in acute myocardial infarction
por: Kreines, VM, et al.
Publicado: (1998) -
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
por: Haddad, Chadia, et al.
Publicado: (2023) -
The hypercoagulable states in anaesthesia and critical care
por: Bande, Bala D, et al.
Publicado: (2014) -
Serum hypercoagulability states in Coats’ disease
por: Ghassemi, Fariba, et al.
Publicado: (2017) -
Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)